Format
Sort by

Send to

Choose Destination

Search results

Items: 3

1.

Risk of cervical HPV infection and prevalence of vaccine-type and other high-risk HPV types among sexually active teens and young women (13-26 years) enrolled in the VALHIDATE study.

Orlando G, Fasolo M, Mazza F, Ricci E, Esposito S, Frati E, Zuccotti GV, Cetin I, Gramegna M, Rizzardini G, Tanzi E; Valhidate Study Group.

Hum Vaccin Immunother. 2014;10(4):986-94. Epub 2014 Jan 15.

2.

Rationale and design of a multicenter prospective cohort study for the eVALuation and monitoring of HPV infections and relATEd cervical diseases in high-risk women (VALHIDATE study).

Orlando G, Tanzi E, Chatenoud L, Gramegna M, Rizzardini G; VALHIDATE Study Group.

BMC Cancer. 2012 May 30;12:204. doi: 10.1186/1471-2407-12-204.

3.

Determinants of adenomyosis in women who underwent hysterectomy for benign gynecological conditions: results from a prospective multicentric study in Italy.

Parazzini F, Mais V, Cipriani S, Busacca M, Venturini P; GISE.

Eur J Obstet Gynecol Reprod Biol. 2009 Apr;143(2):103-6. doi: 10.1016/j.ejogrb.2008.12.010. Epub 2009 Feb 18.

PMID:
19232812

Supplemental Content

Loading ...
Support Center